A look at the latest startups that have emerged in 2018 so far.
There has been endless cash passed out to startups so far but none other that is more intriguing than San Diego’s Gossamer Bio. The company was formed by Faheem Hasnain and Sheila Gujrathi, former CEO and CMO, respectively, of Receptos. Receptos was acquired by Celgene in 2015 for $7.2 billion and the two execs are ready for their next challenge. It’s not clear what the company’s focus is just yet but Gossamer is most definitely a company to watch out for.
Of course, Gossamer Bio is not the only company getting infused with cash.
Here’s a roundup of these stories and other top financial news from the past month.
- Two Former Receptos Execs Launch New San Diego Biotech Startup With $100M
- Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm
- Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area
- Former Pfizer CEO’s Boston Startup Centrexion Lands $67M for Ph3 Osteoarthritis Pain Drug
- KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly
Read More From Karl Thiel:
Can 2018 Possibly Rival 2017’s Biotechs Record Venture Capital Splurge?
